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Abstract The increasing average age in developed
societies is paralleled by an increase in the prevalence
of many age-related diseases such as osteoarthritis
(OA), which is characterized by deformation of the
joint due to cartilage damage and increased turnover
of subchondral bone. Consequently, deficiency in
DNA repair, often associated with premature aging,
may lead to increased pathology of these two tissues.
To examine this possibility, we analyzed the bone and
cartilage phenotype of male and female knee joints
derived from 52- to 104-week-old WT C57Bl/6 and
trichothiodystrophy (TTD) mice, who carry a defect
in the nucleotide excision repair pathway and display
many features of premature aging. Using micro-CT,
we found bone loss in all groups of 104-week-old
compared to 52-week-old mice. Cartilage damage
was mild to moderate in all mice. Surprisingly, female
TTD mice had less cartilage damage, proteoglycan
depletion, and osteophytosis compared to WT con-
trols. OA severity in males did not significantly differ
between genotypes, although TTD males had less
osteophytosis. These results indicate that in premature
aging TTD mice age-related changes in cartilage were
not more severe compared to WT mice, in striking
contrast with bone and many other tissues. This
segmental aging character may be explained by a
difference in vasculature and thereby oxygen load in
cartilage and bone. Alternatively, a difference in
impact of an anti-aging response, previously found
to be triggered by accumulation of DNA damage,
might help explain why female mice were protected
from cartilage damage. These findings underline the
exceptional segmental nature of progeroid conditions
and provide an explanation for pro- and anti-aging
features occurring in the same individual.
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Introduction
During life our DNA is continuously damaged both
from external (e.g., UV radiation and numerous
chemicals) as well as internal (e.g., reactive oxygen
species (ROS)) sources, resulting in numerous types of
DNA lesions (e.g., strand interruptions). If left unre-
paired, some of these lesions can cause mutations upon
replication and consequently trigger carcinogenesis.
Others can block transcription, thereby influencing
cellular functionality and survival, which may affect
lifespan of the organism as a whole (Garinis et al. 2009;
Hoeijmakers 2001).
To counteract this continuous genetic erosion, an
intricate network of DNA repair systems has evolved
that resolves both helix-distorting and non-helix-
distorting types of DNA damage. A molecular pathway
involved in counteracting helix-distorting types of DNA
damage is the nucleotide excision repair (NER) path-
way. NER consists of a complex multi-step ‘cut and
patch’ reaction involving ~30 or more proteins that act
genome wide, designated global genome NER, or
specifically in actively transcribed genes, named
transcription-coupled NER (TC-NER; Hanawalt and
Spivak 2008). TC-NER presumably is part of a broader
transcription-coupled repair system that also elimi-
nates non-helix-distorting type of transcription-
blocking lesions. Since DNA lesions are thought
to affect lifespan, a defective TC(-NE)R contributes
to the process of aging (Schumacher et al. 2008a;
Hoeijmakers 2009). Indeed, human patients with an
inborn defect in TC(-NE)R suffer from a so-called
‘premature aging syndrome’ and show numerous
symptoms that normally develop much later in life,
including sarcopenia, cachexia, progressive neurode-
generation, deafness, early infertility, and osteoporosis.
Many patients die at early age.
An example of such a premature aging syndrome is
trichothiodystrophy (TTD). Most patients suffering
from this rare, autosomal recessive disease have a
mutation in the helicase xeroderma pigmentosum D
(XPD). This protein is a subunit of the transcription/
repair complex TFIIH, which has a multi-functional role
in both normal transcription and in NER. Previously, we
mimicked the TTD phenotype by generating a knock in
mouse carrying anXPD point mutation, found in several
TTD patients (de Boer et al. 1998). The resulting mice
showed striking phenotypical similarities with human
TTD patients, including characteristic brittle hair; scaly
skin; early onset of osteoporosis, kyphosis, and
cachexia; and a shortened lifespan (de Boer et al.
2002; Faghri et al. 2008; Wijnhoven et al. 2005). As
such, they might present an ideal tool to study the
process of aging and age-related diseases.
In the experiment described herein, TTD mice
were used to study a common age-related disease:
osteoarthritis (OA). In OA, the function of a joint
(i.e., to provide friction-less movement) becomes
radically disturbed due to drastic deformation of the
joint components, which leads to severe mobility
problems, pain, and reduction in quality of life.
Currently, no curative treatment is available other
than analgesia and eventually an operation, in which
(part of) the joint is replaced by a prosthesis. Several
joints can be affected but knee OA is a leading cause
of OA-related impairments, affecting more than 4.3
million individuals in the general US population
(Dillon et al. 2006).
The knee joint is composed of several components, to
ensure friction-less yet stable movement under loading
conditions, and each of these components changes
structure and/or becomes damaged in the OA disease
process. The most well known is damage to the smooth
joint surface that is provided by articular cartilage, but
increased turnover of the subchondral bone, located
directly underneath the articular cartilage, is of equal
importance (Karsdal et al. 2008; Lajeunesse 2004). An
additional characteristic of OA is the development of
bony outgrowths at the rims of the joint, named
osteophytes.
Since TTD mice display many characteristics of
age-related diseases which are found in the general
human population, among which OA, we analyzed
subchondral bone changes and cartilage damage in
the knee joint of 52- and 104-week-old wild-type
(WT) and DNA repair deficient, premature aging
TTD mice.
Materials and methods
Generation of TTD knockout mice and selection
of study samples
The generation of the mice used in this study has been
described before (de Boer et al. 1998; Dollé et al.
2006; Wijnhoven et al. 2005). Briefly, gene-targeted
mouse 129Ola ES cells, in which the xpd gene was
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mutated using a point mutation (R722W) found in a
human TTD patient, were injected into C57Bl/6J
blastocysts. Chimeric male mice were mated with
C57Bl/6J females, and heterozygous offspring was
bred into an isogenic C57Bl/6J genetic background
for over 10 generations. In the second round of
breeding, double heterozygous mice were intercrossed
to obtain XPDTTD homozygous mice (from now on
termed TTD mice), which were then used in the third
breeding round to generate the experimental animals
analyzed in this study. The mice were compared to
C57Bl/6J wild-type mice (from now on termed WT
mice). WT mice are known to develop clear signs of
OA from about 16 months (~70 weeks) of age
(Yamamoto et al. 2005; Stoop et al. 1999).
An aging cohort was designed containing WT and
TTD, both males and females (Wijnhoven et al.
2005). All mice were kept in animal facilities of the
RIVM (Bilthoven, The Netherlands) under specific
pathogen-free conditions in groups of four or less per
cage after weaning. The room temperature was 20°C
and the light/dark cycle was 12 h/12 h. Standard lab
chow (Hope Farms, The Netherlands) and water were
supplied ad libitum. Female TTD animals had a
significantly reduced lifespan, with a median survival
age of 103 weeks for WT and 93 weeks for TTD
females (Wijnhoven et al. 2005). Mice were sacrificed
at scheduled ages, including 52-week-old and 104-
week-old mice. The physical condition of all animals
used in the current study was assessed by a
pathologist at sacrifice and only those animals that
had no abnormal characteristics (e.g., tumor growth,
infection) were used in this study. All procedures
were performed in accordance with applicable federal
guidelines and institutional policies.
Micro-computed tomographic scanning
and quantification of bone morphometric parameters
Tibiae from male and female mice, both WT and TTD
were selected for analysis, generating a total of eight
groups of mice (n=6–7 per group). Methods used to
scan and analyze the proximal portion of the tibiae
(see Fig. 1) are described elsewhere (Botter et al.
2006). Briefly, tibiae were fixed in 4% formalin and
scanned in the Skyscan 1072 micro-CT scanner
(Skyscan, Kontich, Belgium) with a voxel size of
10 μm. To distinguish calcified tissue from non-
calcified tissue and noise, the reconstructed greyscale
images were segmented by an automated algorithm
using local thresholds (Waarsing et al. 2004), resulting
in a 3D dataset consisting of stacked black/white cross-
sections. In order to study subchondral bone, the
epiphysis of the tibia was chosen as the region of
interest. The outline of the epiphysis was manually
selected using 3D data analysis software (CTAnalyser,
Skyscan) excluding any outgrowing mineralized
osteophytes. Next, using in-house developed software
(available upon request), the subchondral bone plate
was separated from the subchondral trabeculae for each
cross-section in the 3D dataset. For the epiphysis,
the following 3D morphometric parameters were
calculated using the freely available software package
3D-Calculator (http://www.erasmusmc.nl/orthopaedie/
research/labor/downloads): Trabecular bone volume
fraction (Trab BV/TV), which is the ratio of trabecular
bone volume (Trab BV, in cubic millimeters) over
endocortical tissue volume (TV, in cubic millimeters),
trabecular thickness (Tb.Th., in micrometers), trabecu-
lar spacing (in micrometers), and connectivity density
(dimensionless), indicating the number of trabecular
connections per unit volume (Odgaard and Gundersen
1993). Subchondral bone plate thickness was measured
in the weight-bearing region of the medial and lateral
tibial plateau. At each location, a subset (0.5 mm
mediolateral width, 1.0 mm ventrodorsal length) was
taken as region of interest. We chose to present the
thickness of the subchondral bone plate as an average
of medial and lateral values, since changes in thickness
were very similar for both anatomical locations, and
for reasons of clarity. Thus, values presented here
(Fig. 3c) represent average subchondral bone plate
thickness (Sb.Pl.Th., in micrometers).
As a reference to other published work (especially
with regard to the bone phenotype of WT mice), we
also analyzed the amount of bone (i.e., Trab BV/TV)
of the proximal metaphysis. For this, we selected a
volume of interest located directly underneath the
growth plate, of 1.0 mm height.
Histological analysis
Following decalcification in 10% EDTA for 14 days and
embedding in paraffin, 6-μm thick coronal (frontal)
histological sections were taken through the joint at
100 μm intervals. Sections were stained with Safranin O
and Fast green and cartilage damage was scored using
the semi-quantitative grading and staging system
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devised by the OARSI Working Group (Pritzker et
al. 2006). In this semi-quantitative system, a grade
score reflects severity of damage (0—no damage,
6—complete disorganization and deformation of the
joint), and a stage score indicates extent of damage
(0—cartilage surface intact, 4—>50% of cartilage
surface affected). Grade and stage scores are then
multiplied, resulting in a maximum obtainable
cartilage damage score of 24 for each of the cartilage
surfaces analyzed. Four locations were analyzed
(medial tibial plateau, medial femoral condyle,
lateral tibial plateau, and lateral femoral condyle) in
three histological sections per joint. The cartilage
damage scores thus obtained were averaged over the
three sections and summed over the four locations,
yielding a maximum obtainable summed cartilage
damage score of 96.
Loss of proteoglycans (stained by Safranin O) was
scored using a four-point scoring system from 0 to 3,
where 0 represents no loss of proteoglycans and three
indicates complete loss of staining for proteoglycans
in more than half of the cartilage layer. Scores from
the four anatomical locations were summed to reach a
maximum obtainable score of 12.
As in mice osteophytes are most readily observed
at the medial tibia (Blaney Davidson et al. 2007), this
location was taken to score osteophytosis according to
the 4-point scoring system from Kamekura et al.
(2005), with 0—no osteophytes, 1—formation of
cartilage-like tissues, 2—increase of cartilaginous
matrix, and 3—endochondral ossification.
To measure cartilage thickness, microphoto-
graphs were taken of the medial tibial plateau and
cartilage thickness was measured using Bioquant
Osteo v7.20 (Bioquant, Nashville, TN). This pro-
gram measures thickness of a selected area of
interest (here the cartilage layer) every 10 μm,
producing roughly 80 measurements, which were
then averaged. Thickness of the calcified cartilage
(CC) was measured separately, after which thick-
ness of the non-calcified cartilage (NCC) could be
calculated.
Statistical analysis
Statistics were analyzed with GraphPad Prism
v3.05 (San Diego, CA). When comparing group
averages, non-parametric Mann–Whitney was ap-
plied. For correlations, non-parametric Spearman
rank correlation was used. In all cases p<0.05 was
considered significantly different. In all graphs, data
are presented as mean±standard error of the mean
(SEM).
Results
Body weights
As noted before by Wijnhoven et al. (2005), female
and male WT mice reached a higher body weight than
TTD mice, both at 52 and 104 weeks of age (Fig. 2a).
Fig. 1 Analysis of bone
phenotype of WT and TTD
mice. Anatomical context
with the analyzed region
(proximal tibia) is indicated
in the smaller panel. The
larger panel shows a
transparent 3D model of the
proximal tibia. The
subchondral (epiphyseal)
trabecular bone structure is
indicated in orange (left:
frontal view, right: top
view). The model was build
from a transaxial stack of
cross-sections of 10 μm
thickness. Med medial, lat
lateral, pos posterior, ant
anterior
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No significant changes in weight between these time
points were noted within the female and male
genotypes. The weight differences were mainly due
to the absence of adipose tissue, as became clear at
autopsy during sacrifice. The reduction in fat also
became clear from histological analysis of the bone
marrow: in bone marrow of WT mice many fat
vacuoles were present, in contrast to bone marrow of
TTD mice, which contained almost no fat vacuoles
(Fig. 2b). No differences were found in the length of
either the tibia or the femur between WT and TTDs at
either age (data not shown), indicating that the TTD
animals were skeletally mature and excluding a
developmental delay in growth of the animals.
Fig. 2 a Body weights of
female and male WT and
TTD, aged 52 and
104 weeks. b Gross
histological overview of the
proximal tibia of WT and
TTD mice, aged 104 weeks.
An enlargement
(magnification ×200) of the
metaphyseal bone marrow is
shown below each of the
overview pictures
(magnification ×20). Please
note the absence of fat
vacuoles in the bone
marrow of TTD mice. This
difference was already
visible at 52 weeks, albeit
less clearly (images not
shown)
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Bone changes in knee joints of WT and TTD mice
In all groups of mice a significant amount of trabecular
bone was lost at 104 weeks of age, as shown from the
significant reductions in trabecular bone volume fraction
(Trab BV/TV) in the epiphysis (Fig. 3a) and in the more
distally located metaphysis (Fig. 3b). These findings are
consistent with an aging-related bone decline in both
WT and TTD mice (Halloran et al. 2002; Ferguson et al.
2003; Diderich 2010). When comparing genotypes
within each of the sexes we noticed that, especially in
female mice, the amount of trabecular bone at 52 weeks
of age was already lower in female TTDs compared to
the age-matched WT mice, although this did not reach
statistical significance (females, 52-week-old WT vs.
TTD, p=0.06 for epiphyseal trabecular bone, p=0.07
for metaphyseal trabecular bone). It is important to note
that at young age, the phenotype of TTD animals is not
different from WT mice, but starts to deviate from about
13 weeks of age (Wijnhoven et al. 2005; Diderich
2010). The differences observed at 52 weeks are
therefore in line with previous findings on accelerated
bone loss in female TTD mice.
Interestingly, at the age of 104 weeks TTD males
displayed a further reduction to the same minimum as
observed in TTD and WT females. This might indicate
that the amount of trabecular bone reached a bottom
value (around 15% in epiphysis, 3% in metaphysis)
below which no further bone loss occurred. In WT males
trabecular bone values were highest at 52 weeks and
showed a significant reduction at the age of 104 weeks,
but did not reach the low values observed in WT females
and both TTD genders. Again, these findings are in
agreement with accelerated bone loss in TTD mice.
Fig. 3 Bone changes in female and male WT and TTD mice,
aged 52 and 104 weeks. a Trabecular bone volume fraction (Trab
BV/TV) in tibial epiphysis. b Trab BV/TV in tibial metaphysic. c
Subchondral bone plate thickness in the tibial epiphysis. Please
note that values refer to the average thickness of the medial and
lateral subchondral bone plate. d Thickness of non-calcified
(NCC) and calcified (CC) portion of the cartilage layer. Please
note the decreased values and increased standard error in both
sexes of the 104-week-old WT mice. This was caused due to the
severe cartilage damage in two cases (one mouse in each group),
for which it was not possible to obtain a thickness value. In these
cases ‘0’ was used as value. The histological section (magnifi-
cation ×200) is provided for anatomical context, the dashed line
indicates the border between NCC and CC. Shown are averages
±SEM, significance was tested within genders, with p<0.05
considered significant. Ages are depicted inside the bars. NCC
non-calcified cartilage, CC calcified cartilage, SBP subchondral
bone plate, BM bone marrow
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Consistent with this interpretation, we found that
the thickness of the subchondral bone plate (Sb.Pl.
Th.) in both sexes of TTD mice decreased signifi-
cantly between 52 and 104 weeks, whereas this
decline was not observed in either female or male
WT mice (Fig. 3c). This decrease was caused by
thinning of bone tissue, since the thickness of the
calcified portion of the cartilage layer (which is also
detected by the X-rays used in micro-CT; SMB,
personal observations) did not change in either gender
or genotype (Fig. 3d). Also, no significant changes
were found in the total thickness of the cartilage layer
(Fig. 3d, NCC+CC).
Only small, but systematic reductions in average
epiphyseal trabecular thickness (Tb.Th.) were mea-
sured in both sexes and in both genotypes (female
WT: 52 weeks, 80.6±1.7 μm; 104 weeks, 76.1±
1.3 μm; female TTD: 52 weeks, 78.6±1.1 μm;
104 weeks, 75.0±1.9 μm; male WT: 52 weeks, 77.9
±1.1 μm; 104 weeks, 75.1±1.2 μm; male TTD:
52 weeks, 74.2±1.5 μm; 104 weeks, 69.1±0.5 μm)
and this reduction was statistically significant for the
104-week-old TTD males (p<0.01 compared to 52-
week-old TTD male, p<0.01 compared to 104-week-
old WT male). The frequency distribution of the
measured trabecular thicknesses (Fig. 4, upper panel)
shows an approximate normal distribution. The area
under the curve of each distribution is equal to the
total amount of trabecular bone (Trab BV) inside the
epiphysis. These areas are smaller in all groups of
104-week-old mice, indicating loss of trabecular
bone. Thus, thinning of trabeculae does not fully
explain the decreased amount of subchondral trabec-
ular bone seen in all groups of mice. Equally
important, trabeculae were lost, especially in the
thickness range of 90–150 μm. This was further
substantiated by the trabecular connectivity density,
which dropped significantly in female WT mice (52
weeks, 58.8±17.7; 104 weeks, 0.4±0.4, p<0.05) and
male TTD mice (52 weeks, 78.4±14.4; 104 weeks,
26.7±10.5, p<0.05), and also had a downward trend
in female TTD mice (52 weeks, 39.2±8.3; 104 weeks,
22.6±9.1, p=0.24) and male WT mice (52 weeks,
78.8±7.6; 104 weeks, 49.3±9.4, p=0.05). In line with
these findings, trabecular spacing was significantly
increased in all 104-week-old groups of mice, except
for the 104-week-old WT males (data not shown), who
accordingly had the smallest decrease in subchondral
trabecular bone (shown in Fig. 3a), consistent with the
idea that bone aging in this group was lowest. The
changes in trabecular bone of the tibial epiphysis are
visualized by 3D reconstructions in Fig. 4 (bottom
panel).
Next to a decreased Trab BV (Fig. 4), the reduction
in the amount of trabecular bone (i.e., Trab BV/TV,
Fig. 3a) was also caused by an increase in the total
amount of endocortical tissue volume (TV), thereby
lowering the Trab BV/TV ratio (data not shown). The
increased endocortical TV indicated that with aging,
more space became present inside the epiphysis.
Since the epiphysis itself was not significantly
enlarged during aging in neither females nor males,
we hypothesized that the endocortical thinning of the
subchondral bone plate would explain the increased
TV. We therefore studied the relation between the Sb.
Pl.Th. and TV and found an inverse correlation in
TTD, but not in WT mice (female TTD, 52 and
104 weeks, r=−0.56, p=0.05; male TTD, 52 and
104 weeks, r=−0.72, p<0.01). Thus, in 104-week-old
TTD mice, which had the thinnest subchondral bone
plate (Fig. 2a), TV was large, contributing to a
decrease in Trab BV/TV.
Cartilage changes in knee joints of WT and TTD mice
The most commonly observed type of cartilage damage
was superficial fibrillation, occasionally accompanied
by small fissures down the non-calcified region, mainly
at the lateral side of the tibial plateau (Fig. 5). This type
of damage is similar what has been found by others in
WT mice (Lapvetelainen et al. 1995; Stoop et al.
1999). Cartilage damage values ranged from ~10–30
points out of a maximum of 96 points in all groups of
mice (Fig. 6a). In both sexes of WT mice, cartilage
damage increased from mild at 52 weeks of age to
moderate at 104 weeks of age, although this difference
was only statistically significant in the female mice. In
two cases clear disorganization throughout the joint
was found: 1 out of n=7 in the group of 104-week-old
WT males (summed cartilage damage score 61.3) and
1 out of n=6 in the group of 104-week-old WT females
(summed cartilage damage score 70.8). Compared to
WT females, the female TTD mice had significantly
less cartilage damage both at 52 and 104 weeks of age.
In males the amount of damage was more similar
between genotypes, although the 52-week-old TTD
mice had a trend towards more cartilage damage
compared to age-matched WT mice (p=0.05).
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To find out if a relation existed between the
amount of cartilage damage and changes observed in
the underlying subchondral bone plate, we plotted the
average subchondral bone plate thickness against the
amount of cartilage damage, but no relation was
found between these parameters in any of the mouse
groups. Because within every group of mice, the
highest cartilage damage scores were consistently
Fig. 4 Top panel thickness
distributions of epiphyseal
trabecular bone in female
and male WT and TTD
mice, aged 52 and
104 weeks. The number of
observations of a measured
thickness were counted and
pooled in intervals of 30 μm
of thickness. Please note that
area under the curve depicts
the total amount of
trabecular bone (Trab BV).
Trab BV in males is higher
compared to females, since
males are larger animals, but
this is compensated by TV
(not shown) and both sexes
therefore have similar Trab
BV/TV ratios as depicted in
Fig. 2a, *p<0.05, **p<0.01,
52 vs. 104 weeks. Bottom
panel 3D visualizations of
the epiphyseal trabecular
bone structure, as viewed
from the top. The anatomical
positioning is the same as
shown in Fig. 1 (right)
Fig. 5 Representative examples of cartilage damage at the
lateral tibial plateau in female and male WT and TTD mice,
aged 52 and 104 weeks. Cartilage damage (arrowheads) in
104-week-old female TTD mice was only sporadically
observed, contrary to the other groups of 104-week-old mice.
In addition, Safranin O depletion indicating proteoglycan loss
was observed in all 104-week-old mice, except for the TTD
females. Magnification ×200. C cartilage, SBP subchondral
bone plate, M meniscus, BM bone marrow
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found at the lateral side, where the subchondral bone
plate was thinner compared to the medial side (data
not shown), we checked for a relation by plotting the
separate medial and lateral subchondral bone plate
and cartilage damage values for each anatomical site
(i.e., medial and lateral tibial plateau), but no relation
was found.
At 104 weeks of age, loss of proteoglycans as
assessed by Safranin O depletion was observed in all
but the female TTD mice, in which the cartilage
phenotype remained relatively normal during aging
(Figs. 5 and 6b). At 104 weeks of age, TTD females
had significantly less proteoglycan depletion com-
pared to age-matched female WT mice. In males a
similar amount of proteoglycan depletion was found
in both genotypes, which proved to be significantly
different for TTD males and also had an upward trend
for male WT animals (p=0.07; Fig. 6b).
Finally, osteophytes were observed in 52-week-old
WT mice of both sexes (females, 4 out of n=6; males,
2 out of n=5), and prevalence rose to 100% in the
104-week-old animals (females, 6 out of n=6; males,
7 out of n=7). TTD mice had less osteophytosis at
52 weeks of age (females, 0 out of n=6; males, 1 out
of n=6), and significantly less at 104-week-old of age
(females, 1 out of n=7; males, 4 out of n=6)
compared to age-matched WT animals (Fig. 6c).
Discussion
This is the first study that investigated the link
between DNA repair deficiency as seen in a mouse
model for the DNA repair compromised, premature
aging disorder trichothiodystrophy, and OA-related
changes in cartilage and subchondral bone with aging.
Given the fact that both human TTD patients and
TTD mice present a predominantly progeroid clinical
picture, including prominent osteoporosis, it was
expected that these mice would also display an
increased cartilage damage, a hallmark characteristic
of osteoarthritis (OA). Remarkably, however, not only
did our findings indicate that this was not the case, we
also found that female TTD mice were protected from
Fig. 6 Quantification of histological OA characteristics in knee
joints of female and male WT and TTD mice, aged 52 and
104 weeks. a Cartilage damage, scoring was performed
according to the OARSI Working Group scoring system. b
proteoglycan loss. The staining score is inversely correlated
with of the Safranin O staining intensity, a high score therefore
indicates more proteoglycan loss. c Osteophyte presence at the
medial tibia, a higher score meaning more mature (mineralized)
osteophytes. Shown are averages ±SEM, significance was
tested within genders, with p<0.05 considered significant.
Ages are depicted inside the bars. n.p. not present
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cartilage damage. In sharp contrast, at the level of
(subchondral) bone, we did confirm the accelerated
bone aging phenotype, especially in TTD females.
The question then is, what explains this apparent
tissue difference between bone and cartilage in aging
TTD mice, and why are female mice affected more
than males? Previous results already showed that
other tissues in TTD mice also exhibit a paradoxically
slower rate of aging-related pathology compared to
WT mice. For instance, incidence of age-related
cataract of the eye lens was decreased in TTD mice
as compared to WT littermates (Wijnhoven et al.
2005). An interesting common denominator of both
cartilage and lens tissue is the absence of any
vascular, neuronal, or lymphatic tissue and the post-
mitotic state of the cells, whereas bone (as most other
tissues) is highly vascularized and has a higher
turnover. Epithelial cells of the lens are nourished
via the aqueous humor and anaerobic metabolism is
the primary source of energy (Harding 1997). Artic-
ular cartilage receives its nutrients via the surrounding
synovial fluid which is encapsulated by the knee
capsule, and via the underlying subchondral bone
(Benedek 2006; Huber et al. 2000; Imhof et al. 1999).
Embedded inside their extracellular matrix, the
chondrocytes survive under relative anoxic condi-
tions, with oxygen tensions varying from around 6%
at the joint surface to 1% in the deep layers of healthy
articular cartilage (Pfander and Gelse 2007). In
contrast, blood vessels are commonly observed in
subchondral bone (Imhof et al. 2000), and oxygen is
important for the survival of osteoblasts (Sun and Wei
2009).
Vascularization of a tissue is important for nutrient
and oxygen supply to tissues and cells and for
determining the metabolic capacity of the cells.
However, the downside of oxygen is the generation
of DNA-damaging ROS, which are produced when
oxygen is consumed in the aerobic respiratory chain
of mitochondria. ROS are important for some cellular
processes in both bone and cartilage (Kim et al. 2010;
Rached et al. 2010; Ambrogini et al. 2010; Morita et
al. 2007; Gibson et al. 2008), but high levels of ROS
(i.e., oxidative stress) can lead to increased levels of
oxidative DNA damage which may not be repaired
sufficiently, thereby disturbing normal cellular metab-
olism and increasing the risk for pathology (Wauquier
et al. 2009; Garinis et al. 2009; Hoeijmakers 2001;
Giorgio et al. 2007). The concept of ROS production
in relation to age-related bone loss and development
of osteoporosis has recently been carefully reviewed
by Manolagas (Manolagas 2010) and the significance
of FoxO-mediated defense against oxidative stress for
osteoblast function and skeletal homeostasis has
recently been demonstrated (Rached et al. 2010;
Ambrogini et al. 2010). A role for ROS in OA has
also been discussed in the context of DNA damage,
together with the effect of oxygen tension on ex vivo
chondrocyte function and antioxidant intervention
studies (Henrotin et al. 2005). However, it was
concluded that the role of ROS in cartilage degrada-
tion and development of OA remained an open
question.
The concept of ROS-induced oxidative stress
leading to pathology is especially relevant for a
situation in which the DNA repair system is compro-
mised, as is the case in TTD. However, this concept
also implies that less metabolic active and low oxygen
consuming tissues (such as cartilage and the eye lens)
have reduced sensitivity to age-related accumulation
of DNA damage. Following this argument, oxidative
stress in the nonvascularized cartilage and lens is
expected to be limited compared to bone and other
vascularized tissues, and the presence of only a
partially functional DNA repair system would there-
fore suffice. Our current study therefore strongly
indicates that oxidative damage does not play a major
role in the age-related etiology of cartilage damage
and OA. In this respect, the role of antioxidant
treatment (either taken as supplements or via enriched
dietary intake) may not be effective, and although in
the last decades a number of randomized clinical trials
have been performed which tested the use of supple-
ments as treatment for OA, antioxidant supplementation
so far has not shown clear efficacy (Wluka et al. 2002;
Canter et al. 2007; Brien et al. 2008). Subsequent
direct proof that oxidative damage is not involved in
OA should be provided by genetic studies and age-
related cartilage-specific interference in metabolism,
ROS production and cartilage degradation.
A second explanation for the observed age-related
differences in cartilage and bone between WT and TTD
mice has emerged from microarray expression profile
analysis of other DNA repair-deficient progeroid mouse
mutants, which revealed a ‘survival response’ involving
suppression of the somatotrophic (IGF-1/growth
hormone) axis (Garinis et al. 2009; Niedernhofer et al.
2006; Schumacher et al. 2008b; Van de Ven et al.
AGE
2007). This survival response is a systemic adaptive
response aimed at minimizing further damage to the
DNA, by shifting the energy equilibrium of the organism
from growth and proliferation to preservation of somatic
maintenance. In addition to lowering IGF-1 production,
the survival response stimulates cellular antioxidant
systems and suppresses the production of certain
hormones, such as estrogens, which may also explain
why TTDmice have a lower bonemass compared toWT
mice. This latter finding is of particularly interest, as the
association of low amounts of cartilage damage associ-
ated with (subchondral) osteopenia point to the ‘old’
theory of an inverse relation between OA and osteopo-
rosis (Dequeker et al. 2003). Here, IGF-1 may be a
mechanistic link, since its levels were shown to be
elevated in OA cartilage (Schneiderman et al. 1995) but
its production is generally found to decline with aging
leading to osteoporosis (Perrini et al. 2010). However,
studies looking at the relation between IGF-1 levels and
OA remain inconclusive (Denko and Malemud 2005).
Interestingly, Biermasz and co-workers found that
acromegaly patient having abnormally high circulating
levels of IGF-1 showed an almost fourfold increased
risk for radiological osteoarthritis of the hip (Biermasz
et al. 2009). It would therefore be interesting to
determine both circulating, but probably more impor-
tant, local IGF-1 levels and IGF-I signaling inside the
articular cartilage of old WT and TTD mice and assess
a relation with cartilage damage.
Furthermore, it is possible that nonvascularized and
non-proliferative tissues, such as the cells in the eye lens
and cartilage, profit more from this systemic survival
response, than they suffer from the consequences of the
DNA repair defect in part derived from endogenous
oxidative stress. As a net result these organs and tissues
undergo less pathological changes with aging compared
to vascularized tissues. However, it is currently unknown
whether a (protective) survival response is also present in
cartilage of (female) TTD mice, and cartilage-specific
microarray studies will be instrumental to answer this
question.
A final explanation for the observed differences in
cartilage aging between WT and TTD mice, although
speculative, is the absence of adipose tissue in the latter.
In humans, obesity is one of the major risk factors for
developing OA, and recent studies indicate that, next to
increased body weight and thus increased mechanical
joint load, the adipose tissue itself may also induce or
exacerbate OA, by excreting pro-inflammatory cytokines
such as leptin (Otero et al. 2005; Gabay et al. 2008;
Sandell 2009; Yusuf et al. 2010). However, if this will
hold for TTD mice as well will necessitate extensive
further analyses.
It is difficult to relate our results directly to
observations in the human TTD patients since to our
knowledge, no study has ever reported or looked at OA
development in TTD patients, probably because of the
extreme rarity of the disease and the fact that most
patients die at an age too early for OA development.
With regard to bone changes, some reports stated bone
abnormalities including osteopenia in the long bones and
osteosclerosis in the axial skeleton (Faghri et al. 2008),
but clear sex differences have not been described.
An intriguing and yet unexplained observation in our
study was the difference between female and male TTD
mice. Female TTD mice had less OA development than
TTD males at both ages, whereas in WT mice the OA
severity between both sexes was similar. Studies
comparing spontaneous OA in both male and female
WTmice are scarce but those that are published (usually
serving as controls for genetically modifiedmice) do not
report large differences between genders (Bohm et al.
2005; Lories et al. 2008). However, in some OA
susceptible mouse strains such as the STR/ORT mice,
known to develop progressive cartilage damage at
early age (10–20 weeks of age), males are affected
more than females (Munasinghe et al. 1996). This
finding also holds for instability-induced OA (van
Osch et al. 1993; Ma et al. 2007). These studies
indicate that male mice, when challenged (by joint
instability or genetic modification) are more prone to
develop OA than female mice. This difference between
male and female mice might be further enhanced by
changes in the levels of sex hormones (Schwartz et al.
1994; Sowers et al. 1996; Sniekers et al. 2008).
To summarize, we found that TTD mice, despite
their overall premature aging phenotype, did not have
more, or even had less, OA characteristics compared
to WT mice. This may be explained by a difference in
response of a tissue to the ‘survival response’
triggered by the accumulation of DNA damage, or
by a difference in sensitivity to the DNA damage
itself (or a combination). The outcome of this process
is that some, preferentially nonvascularized, tissues
will remain relatively unaffected, giving this disorder
a segmental nature. This study therefore provides
important clues as to why progeroid syndromes such
as TTD show a segmental pattern of aging.
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